该项收购完成后,Cambrex公司将获得Avista公司包括从原料药、药品开发、环化核苷酸制造,到独立分析、微生物测验以及固态科学等多项服务,同时将Avista的4个制药站点纳入其生...查看全文
琬麟2015-02-07 09:21
$凯姆布雷克斯(CBM)$ EAST RUTHERFORD, N.J., Feb. 6, 2015 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce that it has initiated the second significant expansion of its Charles City, Iowa facility in less than three years. Strong continu...查看全文
$凯姆布雷克斯(CBM)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-19-307820 Act: 33 Size: 38 KB 网页链接
$凯姆布雷克斯(CBM)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-19-307827 Act: 33 Size: 38 KB 网页链接
$凯姆布雷克斯(CBM)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-19-307817 Act: 33 Size: 38 KB 网页链接
$凯姆布雷克斯(CBM)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-19-307807 Act: 33 Size: 38 KB 网页链接
$凯姆布雷克斯(CBM)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-19-307812 Act: 33 Size: 38 KB 网页链接
$凯姆布雷克斯(CBM)$ S-8 POS Securities to be offered to employees in employee benefit plans, post-effective amendments Accession Number: 0001193125-19-307799 Act: 33 Size: 38 KB 网页链接
$凯姆布雷克斯(CBM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-059251 Size: 26 KB 网页链接
$凯姆布雷克斯(CBM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-059246 Size: 31 KB 网页链接
$凯姆布雷克斯(CBM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-059247 Size: 22 KB 网页链接
$凯姆布雷克斯(CBM)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-19-059248 Size: 26 KB 网页链接